Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People of any gender aged 18 or older.
- People who have been diagnosed with active Crohn's disease (CD) affecting the small bowel, with or without involvement of the large bowel, before entering the study.
- People who are experiencing active Crohn's disease symptoms at the time the nutritional treatment begins.
- People whose disease is considered active based on a symptom score (called the Harvey-Bradshaw Index) above 4, plus at least one objective sign of inflammation — such as elevated blood or stool markers, or imaging/camera tests showing active disease (confirm with trial site for exact test details).
- People who are able and willing to follow one of the study's dietary/nutritional programmes.
- People who are able to understand and sign the consent form agreeing to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People experiencing a severe Crohn's flare that involves tunnels forming between organs (fistulas) or narrowed sections of bowel (strictures) during the study.
- People who are currently admitted to hospital.
- People with a known allergy or intolerance to any ingredients in the nutritional supplement called Modulen IBD.
- People who are already following a specific prescribed diet or taking part in another nutrition-related study.
- People who are planned to have surgery during the study period.
- People who currently have an active cancer.
- People who are currently taking antibiotics or probiotic supplements.
- People with other health conditions that could interfere with following the nutritional programme, such as heart disease, coeliac disease, uncontrolled diabetes, active infections, tuberculosis, or a positive stool test for a bacteria called Clostridioides difficile.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bruno Ramos Molina, Investigator of IMIB, Instituto Murciano de Investigación Biosanitaria (IMIB)
Phone: + 34 618 35 71 53
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Body composition
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.